Results 41 to 50 of about 846,625 (333)
Hepatology, 2021 Nonalcoholic steatohepatitis is rapidly becoming the leading cause of liver failure and indication for liver transplantation. Hepatic inflammation is a key feature of NASH but the immune pathways involved in this process are poorly understood.
Fanta Barrow +16 more
semanticscholar +1 more source
Nash functions on noncompact Nash manifolds [PDF]
Annales Scientifiques de l’École Normale Supérieure, 2000 An affine Nash manifold in \(\mathbb{R}^n\) is a semialgebraic analytic submanifold of \(\mathbb{R}^n\). A Nash mapping between affine Nash manifolds is an analytic mapping with semi-algebraic graph. It was shown by \textit{M. Coste}, \textit{J. M. Ruiz} and \textit{M. Shiota} [Compos. Math.
Coste, Michel, Shiota, Masahiro
openaire +2 more sources
Altered synaptic ultrastructure in the prefrontal cortex of Shank3-deficient rats
Molecular Autism, 2020 Background Deletion or mutations of SHANK3 lead to Phelan–McDermid syndrome and monogenic forms of autism spectrum disorder (ASD). SHANK3 encodes its eponymous scaffolding protein at excitatory glutamatergic synapses.
Sarah Jacot-Descombes +12 more
doaj +1 more source
The Connection between MicroRNAs from Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease
Acta Medica, 2021 Non-Alcoholic Fatty Liver Disease (NAFLD) is one of the most important causes of liver disease worldwide leading the foreground cause of liver transplantation.
Veronika Zubáňová +3 more
doaj +1 more source
Neutrophil activation at high-fat high-cholesterol and high-fructose diets induces low-grade inflammation in mice [PDF]
The Ukrainian Biochemical JournalNonalcoholic fatty liver disease (NAFLD), which can progress to nonalcoholic steatohepatitis (NASH), is a significant health concern affecting a substantial portion of the population.
G. Bila +4 more
doaj +1 more source
Strategic behavior in non-atomic games [PDF]
, 2011 In order to remedy the possible loss of strategic interaction in non-atomic games with a societal choice, this study proposes a refinement of Nash equilibrium, strategic equilibrium.
Barlo, Mehmet, Carmona, Guilherme
core +3 more sources
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
New England Journal of MedicineBACKGROUND Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with no approved treatment. Resmetirom is an oral, liver-directed, thyroid hormone receptor beta-selective agonist in development for the treatment of NASH with liver fibrosis.
Stephen A. Harrison +28 more
semanticscholar +1 more source
A Sweet Connection? Fructose’s Role in Hepatocellular Carcinoma
Biomolecules, 2020 Hepatocellular carcinoma is one of few cancer types that continues to grow in incidence and mortality worldwide. With the alarming increase in diabetes and obesity rates, the higher rates of hepatocellular carcinoma are a result of underlying non ...
Brittany Dewdney +4 more
doaj +1 more source
Non-commutative Nash inequalities [PDF]
, 2015 A set of functional inequalities - called Nash inequalities - are introduced and analyzed in the context of quantum Markov process mixing. The basic theory of Nash inequalities is extended to the setting of non-commutative Lp spaces, where their ...
Kastoryano, Michael J., Temme, Kristan
core +2 more sources
Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH
Hepatology Communications, 2021 The rising prevalence of nonalcoholic fatty liver disease (NAFLD) and NAFLD‐related cirrhosis in the United States and globally highlights the need to better understand the mechanisms causing progression of hepatic steatosis to fibrosing steatohepatitis ...
C. Horn +4 more
semanticscholar +1 more source